← All Wire coverage

Situationmaterial

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

Carried more widely than almost anything else in the last 30 days

Reports

59

Domains carrying it

51

First reported

26 August 2026

Latest report

5 September 2026

Sectors

Biotech

Where

United States

Timeline

  1. 26 August 2026FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancerfda.gov
  2. 27 August 2026FDA approves life-extending pancreatic cancer drug Rasonqueusatoday.com
  3. 28 August 2026FDA approves breakthrough pancreatic cancer drug Rasonquefoxnews.com
  4. 29 August 2026'I'm still here:' South Florida patients see early promising results from new pancreatic cancer pillsun-sentinel.com
  5. 30 August 2026'Miracle drug' used by Sasse receives FDA approvalpressreader.com
  6. 31 August 2026Karmanos Now Offers FDA-Approved Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancersg.finance.yahoo.com
  7. 2 September 2026Breakthrough cancer treatment being researched in Arizona receives FDA approval12news.com
  8. 3 September 2026New pancreatic cancer drug gives South Portland man hope for longer lifepressherald.com
  9. 5 September 2026Revolution Medicines drug Rasonoque shows promise against lung cancerfox.com

Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

Share

Wire has not analysed this situation yet

Below is every report Wire has gathered on this event, and the situations it connects to. The deeper analysis — why it happened, what changed, what would prove it wrong — is not written yet, so nothing here claims it.

Evidence

59 reports · 51 domains